List of works - Bernard Masri

Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.

scholarly article

Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein

scientific article (publication date: 11 January 2002)

Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction

scientific article published on 15 June 2017

Apelin promotes lymphangiogenesis and lymph node metastasis.

scientific article

Apelin receptors: From signaling to antidiabetic strategy.

scientific article published on 22 May 2015

Apelin signalling: a promising pathway from cloning to pharmacology.

scientific article

Apelin targets gut contraction to control glucose metabolism via the brain

scientific article

Apelin, a newly identified adipokine up-regulated by insulin and obesity

scientific article

Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins

scientific article published on 4 December 2006

Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactions

scientific article

Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism.

scientific article published in February 2018

Correction: The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator.

scientific article published on 28 October 2010

Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist

scientific article published on 6 February 2013

Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization

scientific article published on 01 August 2007

Expression of the murine msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels

scientific article (publication date: 2002)

Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor

scientific article

Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity

scientific article published on 03 December 2018

Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor

scientific article

Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.

scientific article

Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.

scientific article published on 30 September 2008

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo

scientific journal article

Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.

scientific article published on 14 December 2010

The APJ receptor: a new therapeutic approach in diabetic treatment

scientific article

The Adaptor Protein Gab1 Couples the Stimulation of Vascular Endothelial Growth Factor Receptor-2 to the Activation of Phosphoinositide 3-Kinase

scientific article published in 2006

The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments.

scientific article

The dopamine metabolite 3-methoxytyramine is a neuromodulator

scientific article published in 2010

The intestinal glucose-apelin cycle controls carbohydrate absorption in mice

scientific article published on 10 January 2013

Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart.

scientific article published on 16 November 2017

Therapeutic potential of interfering with apelin signalling.

scientific article published on 2 November 2006

Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas

scientific article published on 5 December 2013

[Apelin signalisation and vascular physiopathology].

scientific article

List of works by Bernard Masri

Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.

Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein

Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction

Apelin promotes lymphangiogenesis and lymph node metastasis.

Apelin receptors: From signaling to antidiabetic strategy.

Apelin signalling: a promising pathway from cloning to pharmacology.

Apelin targets gut contraction to control glucose metabolism via the brain

Apelin, a newly identified adipokine up-regulated by insulin and obesity

Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins

Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactions

Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism.

Correction: The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator.

Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist

Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization

Expression of the murine msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels

Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor

Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity

Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor

Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.

Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo

Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.

The APJ receptor: a new therapeutic approach in diabetic treatment

The Adaptor Protein Gab1 Couples the Stimulation of Vascular Endothelial Growth Factor Receptor-2 to the Activation of Phosphoinositide 3-Kinase

The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments.

The dopamine metabolite 3-methoxytyramine is a neuromodulator

The intestinal glucose-apelin cycle controls carbohydrate absorption in mice

Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart.

Therapeutic potential of interfering with apelin signalling.

Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas

[Apelin signalisation and vascular physiopathology].